Back
Galmed Pharmaceuticals Vs. BioLine Rx Industry Stock Comparison
Sell
33
GLMD
Galmed Pharmaceuticals
Last Price:
0.41
Seasonality Move:
1.04%
Sell
44
BLRX
BioLine Rx
Last Price:
0.64
Seasonality Move:
4.16%
Sell
33
Galmed Pharmaceuticals (GLMD)
is a Sell
Is Galmed Pharmaceuticals a Buy, Sell or Hold?
- The current Galmed Pharmaceuticals [GLMD] share price is $0.40. The Score for GLMD is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- GLMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy, Sell or Hold?
- The current BioLine Rx [BLRX] share price is $0.64. The Score for BLRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BLRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLMD Stock Price Chart
What is Galmed Pharmaceuticals's stock price today?
-
The Galmed Pharmaceuticals share price today is $0.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLMD is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLRX Stock Price Chart
What is BioLine Rx's stock price today?
-
The BioLine Rx share price today is $0.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight buying pressure.
GLMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 53.27 | Buy |
| Chaikin Money Flow: | 28983 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.37 - 0.41) | Buy |
| Bollinger Bands (100): | (0.34 - 0.42) | Buy |
BLRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 42.09 | Sell |
| Chaikin Money Flow: | 180509 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.62 - 0.68) | Sell |
| Bollinger Bands (100): | (0.77 - 1.39) | Sell |
GLMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.4 | Buy |
| 20-day SMA: | 0.39 | Buy |
| 50-day SMA: | 0.37 | Buy |
| 200-day SMA: | 0.47 | Sell |
| 8-day EMA: | 0.4 | Buy |
| 20-day EMA: | 0.39 | Buy |
| 50-day EMA: | 0.38 | Buy |
| 200-day EMA: | 1.21 | Sell |
BLRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.65 | Sell |
| 20-day SMA: | 0.65 | Sell |
| 50-day SMA: | 0.84 | Sell |
| 200-day SMA: | 1.35 | Sell |
| 8-day EMA: | 0.65 | Sell |
| 20-day EMA: | 0.67 | Sell |
| 50-day EMA: | 0.82 | Sell |
| 200-day EMA: | 1.17 | Sell |
Galmed Pharmaceuticals Earnings Growth & GLMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.02 per share.
BioLine Rx Earnings Growth & BLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.10 per share.
Galmed Pharmaceuticals Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioLine Rx Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||